Gudin Jeffrey 4
4 · Virpax Pharmaceuticals, Inc. · Filed Jan 27, 2023
Insider Transaction Report
Form 4
Gudin Jeffrey
DirectorChief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-25+50,000→ 50,000 totalExercise: $0.79Exp: 2033-01-25→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments commencing on January 25, 2024.